Arturo Molina
Chief Tech/Sci/R&D Officer at PROTAGONIST THERAPEUTICS, INC.
Net worth: 1 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dinesh Patel | M | 67 | 16 years | |
| Marsha Fanucci | F | 70 |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 10 years |
| Jane Chung | F | 53 | 3 years | |
| Peter Wirth | M | 73 |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 11 years |
| Harold Selick | M | 69 | 15 years | |
| Thomas Wiggans | M | 72 |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 3 years |
| Wayne Frederick | M | 52 |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 3 years |
| Peter Kolchinsky | M | 47 |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 4 years |
| Selwyn Vickers | M | 64 |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 2 years |
| Connie Matsui | F | 70 | 5 years | |
| Michael Dybbs | M | 49 | 6 years | |
| Ulrich Christian Otte | M | - | 2 years | |
| Bryan Giraudo | M | 48 | 6 years | |
| Jon Wigginton | M | 62 | 4 years | |
| James Panek | M | 71 | 4 years | |
| Heidi Hunter | F | 66 | 3 years | |
| William Waddill | M | 67 | 8 years | |
| Sarah O'Dowd | F | 74 | 4 years | |
| Lewis Williams | M | 74 | 7 years | |
| Samuel Saks | M | 69 |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | 3 years |
| Joseph Lobacki | M | 65 | 7 years | |
| Carena Spivey | F | - | - | |
| Steve Benz | M | - | 2 years | |
| Asif Ali | M | 50 | 2 years | |
| Mohammad Masjedizadeh | M | - | 7 years | |
| Irena Webster | F | - |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | - |
| Matthew M. Gosling | M | 53 | 4 years | |
| Werner Rubas | M | - | 3 years | |
| Craig Berman | M | - | 4 years | |
| Diana Landa | F | - | 4 years | |
| Regina Cheng | F | - | 4 years | |
| Carter J. King | M | 52 | 6 years | |
| Suneel Gupta | M | 66 | 5 years | |
| Thomas Haagen | M | 58 | 2 years | |
| Michael Dambach | M | 57 | 17 years | |
| Daniel Swisher | M | 61 | 1 years | |
| Pat Basu | M | - |
Stanford Medical Alumni Association
| - |
| Ashok Bhandari | M | - | 7 years | |
| Craig Ostroff | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alan Auerbach | M | 54 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | 6 years |
| Richard Miller | M | 73 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 18 years |
| William Young | M | 79 | 11 years | |
| William Rastetter | M | 76 | 19 years | |
| Daniel Janney | M | 58 | - | |
| Frank Lee | M | 56 | 3 years | |
| Eric S. Hoffman | M | 54 | 5 years | |
| Robert A. Hamm | M | 72 | 7 years | |
| Charles R. Eyler | M | 76 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | 5 years |
| Lindsay Rosenwald | M | 68 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | 4 years |
| Shalini Sharp | F | 49 | 5 years | |
| V. Lawlis | M | 72 | 16 years | |
| Sarah Noonberg | M | 56 | 6 years | |
| Samantha Truex | F | - | 8 years | |
| Patrick F. Kelly | M | 60 | 6 years | |
| Joseph Mara | M | 49 | - | |
| Timothy Clackson | M | 58 | 4 years | |
| Jami Taylor | M | - | 2 years | |
| Phillip Schneider | M | 67 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 16 years |
| Arie Belldegrun | M | 74 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | 6 years |
| Craig Eric Schneier | M | 76 | 8 years | |
| Christopher Watt | M | 59 | 11 years | |
| Scott Anthony Climes | M | 59 | 2 years | |
| Maiken Keson-Brookes | F | 52 | 5 years | |
| Richard Francis | M | 55 | 8 years | |
| Mark Meltz | M | 50 | 5 years | |
| Michael Gilman | M | 69 | 6 years | |
| Ben Harshbarger | M | 55 | 5 years | |
| Gisele Dion | F | 57 | 9 years | |
| Andrea DiFabio | F | 55 | 11 years | |
| John Cox | M | 61 | 14 years | |
| James Basta | M | 58 | - | |
| Joseph J. Kenny | M | - | 5 years | |
| Michael Pollock | M | - | 2 years | |
| Robert Perez | M | 59 | 8 years | |
| Mark Bodenrader | M | 51 | - | |
| Thomas F. Keller | M | 92 | - | |
| Bethany Sensenig | F | 48 | 13 years | |
| Esther Alegria | M | 66 | 10 years | |
| Robert Gagnon | M | 49 | 7 years | |
| Cecil B. Pickett | M | 78 | 3 years | |
| Katherine J. Turner | M | 70 | 4 years | |
| John Dunn | M | 72 | 9 years | |
| Burt Adelman | M | 71 | 16 years | |
| David Hallal | M | 57 | 2 years | |
| Lawrence C. Best | M | 75 | - | |
| Stephen Tulipano | M | 65 | 8 years | |
| Faheem Hasnain | M | 65 | 4 years | |
| Michael D. Kowolenko | M | 68 | - | |
| Carol Gallagher | M | 59 | 1 years | |
| Bonne Adams | F | 47 | 2 years | |
| Eric W. Kimble | M | 58 | 5 years | |
| Anne Cook | F | 62 | 13 years | |
| Melissa Morandi | F | 59 | 2 years | |
| Dinah Sah | M | 63 | 6 years | |
| Daniel Char | M | 63 | 11 years | |
| Pratik Multani | M | 57 | 5 years | |
| Alessandra Cesano | M | 63 | 2 years | |
| John McCabe | M | 55 | 2 years | |
| Allen Kamer | M | 53 | 3 years | |
| Timothy Kelly | M | 55 | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Arturo Molina
- Personal Network
